Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

Phase 2
5(100.0%)
5Total
Phase 2(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05948579Phase 2Not Yet Recruiting

Department of Defense PTSD Adaptive Platform Trial - Intervention B - Vilazodone

Role: collaborator

NCT05948540Phase 2Recruiting

Department of Defense PTSD Adaptive Platform Trial - Intervention C - Daridorexant

Role: collaborator

NCT05422612Phase 2Recruiting

Department of Defense PTSD Adaptive Platform Trial - Master Protocol

Role: collaborator

NCT05948553Phase 2Recruiting

Department of Defense PTSD Adaptive Platform Trial - Intervention A - Fluoxetine

Role: collaborator

NCT06816433Phase 2Not Yet Recruiting

Department of Defense PTSD Adaptive Platform Trial - Intervention D - SLS-002

Role: collaborator

All 5 trials loaded